A practical reference on trans-3-hexenoyl: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-22 and is reviewed periodically as new material appears.
Tesamorelin occupies a narrow position among agents that act on the growth hormone axis. Unlike growth hormone itself, which is given as replacement, it stimulates the pituitary to release the hormone in pulses, so the downstream increase in insulin-like growth factor 1 depends on intact somatotroph function. Other peptides in the same family include shorter GHRH fragments and synthetic secretagogues with different stability profiles. Several points remain unresolved, including whether the reduction in visceral fat translates into fewer cardiovascular events, what happens to metabolic markers after long-term use, and how the drug compares with lifestyle or surgical approaches.
Tesamorelin is a synthetic peptide that belongs to the growth hormone-releasing hormone family and contains the same forty-four amino acid sequence as endogenous GHRH, extended at the amino terminus by a trans-3-hexenoyl group. That small fatty acid modification protects the peptide from rapid cleavage by dipeptidyl peptidase-4, the enzyme that shortens the half-life of native GHRH to only a few minutes. Chemically the compound is produced by solid-phase peptide synthesis, purified by chromatography, and supplied as a sterile lyophilized powder for reconstitution.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
| Property | Value | Notes |
|---|---|---|
| Peptide class | Synthetic GHRH analogue | 44 residues; N-terminal trans-3-hexenoyl group |
| First approval year | 2010 | United States; HIV-associated abdominal fat accumulation |
| Administration route | Subcutaneous injection | Abdominal site; clinician-administered or self-injected |
| Common synonyms | TH9507; tesamorelin acetate | Development code and acetate salt form |
| Originator | Canadian biotechnology firm | Original developer and regulatory sponsor |
A documented effect of tesamorelin is a reduction in visceral adipose tissue in some study populations. Researchers have reported decreases in trunk fat measured by computed tomography alongside changes in lipid markers. The mechanism is thought to involve growth hormone-mediated lipolysis, though the precise contribution of direct versus indirect pathways is not fully resolved. Studies have generally examined defined groups over finite periods, so long-term outcomes are less well characterized. Findings have not been uniform across all trials.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH). Its sequence corresponds to the 44-amino-acid form of human GHRH with a trans-3-hexenoyl group attached to the N-terminal tyrosine. This modification slows enzymatic cleavage and extends the peptide's activity relative to the native hormone. The compound is produced by solid-phase peptide synthesis and supplied as a lyophilized powder. Researchers classify it as a GHRH receptor agonist. Its structure places it in the same family as other growth hormone secretagogues that act on the pituitary.
Measuring the effect of a growth hormone-releasing hormone analogue requires markers that reflect pituitary output rather than the peptide itself. The two most frequently used are growth hormone and insulin-like growth factor 1. Growth hormone fluctuates sharply across the day and responds to sleep, stress, and meals, so isolated readings can be difficult to interpret. Insulin-like growth factor 1 changes more slowly and is often treated as the more stable integrated marker of axis activity.
Because growth hormone is released in pulses, single measurements can misrepresent overall secretion. Investigators sometimes use repeated sampling or overnight profiles to capture the pattern rather than a single value. Provocative testing, in which a stimulus is given and the response is tracked over time, offers another way to characterize the axis. Each approach carries trade-offs between sensitivity, burden on the participant, and the influence of non-target variables.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
Tesamorelin is a synthetic peptide built from 44 amino acids and classified with the growth hormone–releasing hormone family. Its sequence corresponds to the human GHRH(1-44) backbone, carrying one structural change at the amino terminus. That change is a trans-3-hexenoyl group placed where the natural peptide would have an unmodified end. The modification is the feature that separates the compound from the endogenous hormone in name, in stability, and in how it is handled in the laboratory.
=== Electromagnetism === In classical electromagnetism, the vacuum of free space, or sometimes just free space or perfect vacuum, is a standard reference medium for electromagnetic effects. Some authors refer to this reference medium as classical vacuum, a terminology intended to separate this concept from QED vacuum or QCD vacuum, where vacuum fluctuations can produce transient virtual particle densities and a relative permittivity and relative permeability that are not identically unity. In the theory of classical electromagnetism, free space has the following properties:
Following his conviction on 12 May, David Boyd is sentenced to a minimum term of 29 years in prison for Nikki Allan's murder. The Cabinet Office refers former prime minister Boris Johnson to the police following fresh allegations of rule breaches during the COVID-19 pandemic. 24 May Inflation is reported to have fallen from 10.1% in March to 8.7% in April. Food price growth remains close to record highs, at 19.1%. Prime Minister Rishi Sunak confirms that Home Secretary Suella Braverman's handling of a speeding offence did not breach ministerial rules and that she will not face an investigation. 25 May Net migration into the UK during 2022 is reported to have reached a record high of 606,000, with immigration estimated at 1.2m and emigration at 557,000. Around 114,000 people came from Ukraine and 52,000 from Hong Kong. Three activists from climate change protest group Just Stop Oil are arrested for criminal damage after disrupting the Chelsea Flower Show. Armed officers arrest a man after he crashes a car into the gates of Downing Street. The incident is not terrorism related. 26 May British Cycling announces that transgender women are to be banned from the female category of its competitions, following a nine-month review and consultation. This follows the March ban by UK Athletics. Phillip Schofield announces he is leaving ITV, following his recent departure from This Morning amid controversy over the relationship he had with a "much younger" male colleague. Passengers arriving into the UK face delays at several airports after passport e-gates stop working.
Break any disulfide bridges in the protein with a reducing agent like 2-mercaptoethanol. A protecting group such as iodoacetic acid may be necessary to prevent the bonds from re-forming. Separate and purify the individual chains of the protein complex, if there are more than one. Determine the amino acid composition of each chain. Determine the terminal amino acids of each chain. Break each chain into fragments under 50 amino acids long. Separate and purify the fragments. Determine the sequence of each fragment. Repeat with a different pattern of cleavage. Construct the sequence of the overall protein.
Lithium fluoride had already been proposed in the USA in 1950 by Farrington Daniels (1889-1972), Charles A. Boyd and Donald F. Saunders (1924-2013) for solid-state dosimetry using thermoluminescent dosimeters. The intensity of the thermoluminescent light is proportional to the amount of radiation previously absorbed. This type of dosimetry has been used since 1953 in the treatment of cancer patients and wherever people are occupationally exposed to radiation. The thermoluminescence dosimeter was followed by OSL dosimetry, which is not based on heat but on optically stimulated luminescence and was developed by Zenobia Jacobs and Richard Roberts at the University of Wollongong (Australia). The detector emits the stored energy as light. The light output, measured with photomultipliers, is then a measure of the dose.
Sources: en.wikipedia.org
=== Historical misuse === Opiate misuse has been recorded at least since 300 BC. Greek mythology describes Nepenthe ("free from sorrow") and its use by the hero of the Odyssey. Opioids have been used in the Near East for centuries. They were purified and isolated in the early 19th century. In the early 2000s, buprenorphine was one of the first opioid dependence drugs approved in the U.S. to combat opioid abuse, after decades of research led to the development of drugs to fight opioid use disorder.
Defenders said that in addition to its modest efficiency, belimumab allowed patients to significantly reduce their use of corticosteroids. Belimumab was not effective in Phase II clinical trials for rheumatoid arthritis. It was moderately effective in Phase II trials for Sjögren syndrome. In December 2020, belimumab was approved by the FDA as a treatment for lupus nephritis in combination with standard treatment.
The first patch for the Xbox 360 version was released about two weeks after release to fix some of the game stability issues players had reported. The patch was found to introduce more problems to the game for some users, including occasional freezes, bad framerates, and audio-related issues, though methods to resolve these issues through the console's cache system were outlined by Irrational Games. In December 2007, a common patch was released for both the Xbox 360 and Windows version. The patch included additional content such as new Plasmids, new achievements for the Xbox 360 version, and a FOV lock that allowed widescreen players a wider field of view without losing vertical information. The patch also added in an option to disable the use of Vita-Chambers, a feature requested by players to make the game more challenging, as well as an achievement to complete the game at its hardest setting without using a Vita-Chamber. In 2014, 2K Games released a DRM-free version of BioShock in the Humble 2K Bundle, followed by DRM-free releases on GOG in 2018.
However, a 2019 Cochrane review comparing effects of adding oxandrolone to growth hormone treatment to growth hormone alone found moderate-quality evidence that the addition of oxandrolone led to an increase in final adult height of girls with Turner syndrome, and low-quality evidence showed no increase in adverse effects. When the same review assessed the effects of adding oxandrolone to growth hormone treatment on speech, cognition and psychological status, the results were inconclusive due to very-low quality evidence. Children with idiopathic short stature or Turner syndrome were given doses of oxandrolone far smaller than those given to people with burns. Oxandrolone shows positive effects on cardiometabolic health and visual, motor, and psychosocial functions in adolescent males with preserved testosterone production, such as those with Klinefelter syndrome.
== Current food inflation == On 16 February 2025, Mohsen Baghaei, a workers' representative on the Supreme Labor Council, warned of steep price hikes in essential goods over the past two months, with cooking oil up 40%, rice nearly doubling, and staples like potatoes and onions also surging. He estimated that the average worker’s cost-of-living basket has risen over 30% in this period, jumping from 300 million rials ($325) to 380 million rials ($413). According to Iran international as of February 2025 the price of one kg of kiwi equals 2% of the average income. On 23 February 2025, a government agency announced an annual rate of 35%. However, labor groups and analysts argue that the government minimizes negative economic news, implying that the actual inflation rate is considerably higher. The Iranian rial has depreciated by more than 50% over the past six months, fueling expectations of even higher inflation. Currently, the minimum wage is approximately $120 per month, while semi-official estimates suggest that a family of three requires at least $400 per month to meet its basic needs. With Nowruz 2025 approaching, food prices are surging. Approximately one-third of essential food items have experienced price hikes between 30% and 50%, with some items increasing by over 50%. Meanwhile, wages remain low, as the minimum monthly wage for a worker with two children is just $120. In 1403 (Iranian calendar) food prices rose by 70%, packaging costs rose in some cases by 200%, and freight charges climbed 55%. The secondary tariffs which U.S. president Donald J.
Sources: en.wikipedia.org
==== July 2025 rescissions ("claw backs"), but not for PEPFAR ==== In June 2025, the White House requested that Congress pass a package of rescissions, or "claw backs", of approximately $8 billion in foreign aid and $1 billion for the Corporation for Public Broadcasting including NPR and PBS. The House of Representatives passed the cuts as requested. The Senate excluded the PEPFAR cuts, which is the program started in 2003 during the presidency of George W Bush to help provide HIV medicines to lower-income countries. The Senate passed two preliminary votes in close 51-50 fashion with Vice President JD Vance casting the tie-breaking votes. A rescission is one of the exceptions to the Senate's 60-vote filibuster rule. President Trump focused on the public broadcasting aspect, criticizing CNN and also "MSDNC" which is a mix of MSNBC and DNC (Democratic National Committee). In a Truth Social post, he wrote, "It is very important that all Republicans adhere to my Recissions Bill and, in particular, DEFUND THE CORPORATION FOR PUBLIC BROADCASTING (PBS and NPR), which is worse than CNN & MSDNC put together." In a late night session at 2:00 AM on July 17, the Senate voted 51–48 in favor of the cuts. Later that same day, the House of Representatives voted 216 - 213 for the Senate version, meaning PEPFAR was protected in the amount of $400 million. Regarding the cuts to public broadcasting, service to rural areas became one of the political issues.
Positive bottles with negative Gram stains are subcultured before being returned to the incubator, often using special culture media that promotes the growth of slow-growing organisms. It typically takes 24 to 48 hours for sufficient growth to occur on the subculture plates for definitive identification to be possible. At this point, the microbiologist will assess the appearance of the bacterial or fungal colonies and carry out tests that provide information about the metabolic and biochemical features of the organism, which permit identification to the genus or species level. For example, the catalase test can distinguish streptococci and staphylococci (two genera of Gram-positive cocci) from each other, and the coagulase test can differentiate Staphylococcus aureus, a common culprit of bloodstream infections, from the less pathogenic coagulase-negative staphylococci.
=== Cellular effects of C-peptide === C-peptide has been shown to bind to the surface of a number of cell types such as neuronal, endothelial, fibroblast and renal tubular, at nanomolar concentrations to a receptor that is likely G-protein-coupled. The signal activates Ca2+-dependent intracellular signaling pathways such as MAPK, PLCγ, and PKC, leading to upregulation of a range of transcription factors as well as eNOS and Na+K+ATPase activities. The latter two enzymes are known to have reduced activities in patients with type I diabetes and have been implicated in the development of long-term complications of type I diabetes such as peripheral and autonomic neuropathy. In vivo studies in animal models of type 1 diabetes have established that C-peptide administration results in significant improvements in nerve and kidney function. Thus, in animals with early signs of diabetes-induced neuropathy, C peptide treatment in replacement dosage results in improved peripheral nerve function, as evidenced by increased nerve conduction velocity, increased nerve Na+,K+ ATPase activity, and significant amelioration of nerve structural changes. Likewise, C-peptide administration in animals that had C-peptide deficiency (type 1 model) with nephropathy improves renal function and structure; it decreases urinary albumin excretion and prevents or decreases diabetes-induced glomerular changes secondary to mesangial matrix expansion. C-peptide also has been reported to have anti-inflammatory effects as well as aid repair of smooth muscle cells.
=== Immune regulation and pregnancy-associated disorders === Beyond cancer, ITGA1 (also known as CD49a) plays an important role in immune cell regulation, particularly in decidual natural killer (dNK) cells. CD49a (ITGA1) is highly expressed on dNK cells, and reduced CD49a expression has been observed in dNK cells from patients with recurrent spontaneous abortion (RSA), suggesting that impaired ITGA1 signaling may contribute to and pregnancy complications. CD49a regulates dNK cell function by influencing migration, adhesion, and expression of cytotoxic molecules (perforin, granzyme B, interferon-γ). Long non-coding RNA Inc-49a has been identified as a positive regulator of CD49a expression, indicating that ITGA1 may be controlled through RNA-mediated regulatory mechanisms in immune cells.
Sources: en.wikipedia.org
It is a laboratory-made peptide of forty-four amino acids whose sequence matches human growth hormone-releasing hormone, with a modified amino terminus. The modification is a short unsaturated fatty acid chain attached to the first residue. This change slows enzymatic breakdown and lengthens the time the peptide stays active in circulation.
The clinical program was designed around HIV-associated lipodystrophy, a condition in which fat accumulates abnormally around the internal organs. Trials enrolled that specific population, so the evidence base covers it rather than the general population. Regulators approved the drug for the studied indication only, and promotion outside it is not permitted.
Growth hormone therapy supplies the finished hormone directly, while this peptide acts upstream and asks the pituitary to secrete its own. That difference means the response depends on a functioning pituitary and on the body's normal feedback loops. It also means the circulating hormone profile is pulsatile rather than a flat, injected level.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.